The NELSON trial is the first randomised lung cancer screening trial in which pulmonary nodule management is based on volumetry. This led to considerably less false-positive referrals compared to other lung cancer screening trials, with very high negative predictive values found in the first and second screening rounds. Mortality results are still pending, but the knowledge already gained in the NELSON trial and its side-studies provide valuable information in the field of screening for lung cancer.
- Lung neoplasms
- SEMIAUTOMATED VOLUME MEASUREMENTS
- SMALL PULMONARY NODULES
- SPIRAL CT
- DOSE CT